Skip to content
healthcare.dev

Fuligo

NDC 85816-2060, Cimicifuga, Drosera, Formica Rufa, Fuligo, Inula hel., Kali mur, lapis albus, silicea, liquid, from BM Private Limited.

Product NDC
85816-2060
Status
Listed
Labeler
BM Private Limited
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85816-2060 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BLACK COHOSH6 [hp_X]/mL
  • DROSERA ROTUNDIFOLIA WHOLE6 [hp_X]/mL
  • SILICON DIOXIDE6 [hp_X]/mL
  • CALCIUM HEXAFLUOROSILICATE6 [hp_X]/mL
  • INULA HELENIUM ROOT6 [hp_X]/mL
  • FORMICA RUFA6 [hp_X]/mL
  • POTASSIUM CHLORIDE6 [hp_X]/mL

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
85816-2060-18581620600130 mL in 1 BOTTLE, GLASS (85816-2060-1)
85816-2060-285816206002500 mL in 1 BOTTLE, GLASS (85816-2060-2)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85816-2060 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85816-2060 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85816-2060. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.